Details

Last Funding Type

Convertable Note

Last Funding Money Raised

$5M

Industries

Biotechnology,Health Care,Health Diagnostics,Therapeutics

Founded date

Jan 1, 2011

Number Of Employee

11 - 50

Operating Status

Active

AsclepiX Therapeutics represents the next generation of biologics and drug development technology. They use bioinformatics and systems biology methods to design classes of short biomimetic anti-angiogenic (anti-neovascular), and anti-lymphangiogenic peptides. They also use the latest developments in biomaterials and drug delivery to design long-lasting biodegradable nano and microparticles to deliver these biomimetic therapeutic peptides throughout the body.

AsclepiX Therapeutics utilizes its platform technology for indications in ophthalmology, oncology, and for other angiogenesis and lymphangiogenesis-dependent diseases.